Targeting c-met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma.
Zhang Y, Gao H, Zhou W, Sun S, Zeng Y, Zhang H, Liang L, Xiao X, Song J, Ye M, Yang Y, Zhao J, Wang Z, Liu J.
Zhang Y, et al. Among authors: gao h.
J Cell Mol Med. 2018 Dec;22(12):5978-5990. doi: 10.1111/jcmm.13870. Epub 2018 Oct 24.
J Cell Mol Med. 2018.
PMID: 30353654
Free PMC article.